| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $949K | +58.2K | +29.39% | $16.31 | 256K | Dec 29, 2023 | Direct | F1 |
| transaction | BSX | Common Stock | Sale | -$4.71M | -81.9K | -31.99% | $57.50 | 174K | Dec 29, 2023 | Direct | F1 |
| transaction | BSX | Common Stock | Options Exercise | $0 | +21.8K | +12.51% | $0.00 | 196K | Jan 1, 2024 | Direct | F2 |
| transaction | BSX | Common Stock | Tax liability | -$631K | -10.9K | -5.56% | $57.81 | 185K | Jan 1, 2024 | Direct | |
| holding | BSX | Common Stock | 68K | Dec 29, 2023 | By 401(k) | F3 | |||||
| holding | BSX | Common Stock | 4.34K | Dec 29, 2023 | By Child | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Stock Option (Right to Buy) | Options Exercise | $0 | -58.2K | -100% | $0.00* | 0 | Dec 29, 2023 | Common Stock | 58.2K | $16.31 | Direct | F1, F5 |
| transaction | BSX | Performance Share Units | Options Exercise | $0 | -21.8K | -100% | $0.00* | 0 | Jan 1, 2024 | Common Stock | 21.8K | Direct | F2, F6 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 15, 2023, intended to comply with the prior version of Rule 10b5-1(c). |
| F2 | On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2023. |
| F3 | Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. |
| F4 | The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose. |
| F5 | Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant. |
| F6 | Each performance shares unit represents the Company's commitment to issue one share of Boston Scientific common stock. |